Journal Search Engine
Search Advanced Search Adode Reader(link)
Download PDF Export Citaion korean bibliography PMC previewer
ISSN : 1225-0082(Print)
ISSN : 2288-1905(Online)
The Medical Journal of Chosun University Vol.39 No.1 pp.1-8
DOI :

세기조절방사선치료의 임상적 응용

오윤경*
조선대학교 의학전문대학원 방사선종양학교실

Clinical Application of Intensity-Modulated Radiation Therapy

Yoon Kyeong Oh
Department of Radiation Oncology, School of Medicine, Chosun University
(Received February 20, 2014; Accepted March 17, 2014)

Abstract

Intensity-modulated radiation therapy (IMRT) is a radiation technique that has garnered recent interest and is being frequentlyused. IMRT is made possible using computer-controlled multileaf collimators, which are moved according to radiationtherapy planning. IMRT is a form of radiation therapy based on variations in radiation intensity within each beam, and itprovides optimal cover for tumors as well as spares critical normal tissues. Further, the major goal of IMRT is to reducetoxicity. Clinical evidence of level I provides rationale for whole breast as well as head and neck IMRT. Variable levels ofevidence exist for other tumor sites.

 

Reference

1.Starkschall G, Dong L, Balter PA, Shiu AS, Mourtada F, Gillin M, Mohan R. Clinical radiation oncology physics. In: Cox JD, Ang KK. Radiation oncology. 9th ed. Philadelphia: Mosby 2010; 50-91.
2.Xia P, Xing L, Amols HI, Ling CC. Three-dimensional conformal radiotherapy and intensity-modulated radiotherapy. In: Hoppe RT, Phillips TL, Roach M. Leibel and Phillips textbook of radiation oncology. 3rd ed. Philadelphia: Elsevier Saunders 2010; 170-92.
3.Boyer AL, Ezzell GA, Yu CX. Intensity-modulated radiation therapy. In: Khan FM and Gerbi BJ. Treatment planning in radiation oncology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins 2012; 201-28.
4.Park JG, Bang YJ, Ha SW. Oncology. 2nd ed. Seoul: Ilchokak 2012; 180-6.
5.Keum KC. Helical tomotherapy: image-guided intensity modulated radiation therapy. J Korean Med Assoc 2008; 51: 619-29.
6. Ahn YC. Introduction of intensity modulated radiation therapy. J Korean Med Assoc 2011; 54:1172-8.
7. Lee CG. High precision radiotherapy. J Korean Med Assoc 2004; 47: 663-71.
8.Cho JH. Radiation treatment for prostate cancer. J Korean Med Assoc 2004; 47: 424-31
9.International Commission on Radiation Units and Measurements. Prescribing, Recording, and Reporting Photon Beam Therapy (supplement to ICRU report 50). ICRU Report 62. Bethesda, MD: International Commission on Radiation Units and Measurements, 1999.
10.Kim SJ, Lee MJ, Youn SM. Quality assurance of intensity modulated radiation therapy: site-specific results of Eulji University Hospital. J Korean Soc Ther Radiol Oncol 2011; 29: 99-106.
11. Ten Haken RK, Lawrence TS. The clinical application of intensity-modulated radiation therapy. Seminars in Rad Oncol 2006; 16: 224-31.
12.Neve WD, Gersem WD, Madani I. Rational use of intensity-modulated radiation therapy: The importance of clinical outcome. Seminars in Rad Oncol 2012; 22: 40-9.
13.Pow EH, Kwong DL, McMillan AS, Wong MC, Sham JS, Leung LH, Leung WK. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 2006; 66: 981-91.
14. Pignol J, Olivotto I, Rakovitch E. Plenary 1: phase III randomized study of intensity modulated radiation therapy versus standard wedging technique for adjuvant breast radiotherapy. Int J Radiat Oncol Biol Phys 2006; 66: S1.
15. Donovan E, Bleakley N, Denholm E, Evans P, Gothard L, Hanson J, Peckitt C, Reise S, Ross G, Sharp G, at al. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol 2007; 82: 254-64.
16.Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, Miles EA, Miah AB, Newbold K, Tanay M, et al. PARSPORT trial management group. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011; 12: 127-36.
17.Kam MK, Leung SF, Zee B, Chau RM, Suen JJ, Mo F, Lai M, Ho R, Cheung K, Yu BK, et al. Prospective randomised study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 2007; 25: 4873-9.
18.Pignol JP, Olivotto I, Rakovitch E, Gardner S, Sixel K, Beckham W, Vu TT, Truonq P, Ackerman I, Paszat L. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 2008; 26: 2085-92.
19.Barnett GC, Wilkinson JS, Moody AM, Wilson CB, Twyman N, Wishart GC, Burnet NG, Coles CE. Randomized controlled trial of forward-planned intensitymodulated radiotherapy for early breast cancer: Interim results at 2 years. Int J Radiat Oncol Biol Phys 2012; 82: 715-23.
20.Livi L, Buonamici FB, Simontacchi G, Scotti V, Fambrini M, Compagnucci A, Paiar F, Scoccianti S, Pallotta S, Detti B, et al. Accelerated partial breast irradiation with IMRT: New technical approach and interim analysis of acute toxicity in a phase III randomized clinical trial. Int J Radiat Oncol Biol Phys 2010; 77: 509-15.
21. Daly-Schveitzer N, Julieron M, Tao YG, Moussier A, Bourhis J. Intensity-modulated radiation therapy (IMRT): Toward a new standard for radiation therapy of head and neck cancer? Eur Annals Otorhino, Head and Neck dis 2011; 128: 241-7.
22. Lee SH, Kim TH, Chie EK, Im HS, Im ES, Ryu JS, Jung YS, Park SY, Kim JY, Pyo HR, et al. Evaluation of xerostomia following intensity modulated radiotherapy (IMRT) for head and neck cancer patients. J Korean Soc Ther Radiol Oncol 2004; 22: 106-14.
23. Emami B, Lyman J, Brown A, Cola L, Goitein M, Munzenrider JE, Shank B, Solin LJ, Wesson M. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991; 21: 109-22.
24.Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA. Dose, volume, and function relationships in parotid glands following conformal and intensity modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999; 45: 577-87.
25.Clavel S, Nguyen DH, Fortin B, Despres P, Khaouam N, Donath D, Soulieres D, Guertin L, Nguyen PF. Simultaneous intergrated boost using intensity-modulated radiotherapy compared with conventional radiotherapy in patients treated with concurrent carboplatin and 5-fluorouracil for locally advanced oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2012; 82: 582-9.
26. Alongi F, Fiorino C, Cozzarini C, Broggi S, Perna L, Cattaneo GM, Calandrino R, Muzio ND. IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy. Radiother Oncol 2009; 93: 207-12.
27.Park SW, Oh DH, Bae HS, Cho BC, Park JH, Han SH. Application of intensity modulated radiation therapy (IMRT) in prostate cancer. J Korean Soc Ther Radiol Oncol 2002; 20: 68-72.
28.Zelefsky MK, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A, Amols HI. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008; 70: 1124-9.
29.Al-Mamgani A, Heemsbergen WD, Peeters ST, Lebesque JV. Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer. Int J Radiat Oncol Biol Phys 2009; 73: 685-91.
30. McDonald MW, Godette KD, Butker EK, Davis LW, Johnstone PA. Long-term outcome of IMRT for breast cancer: a single-institution cohort analysis. Int J Radiat Oncol Biol Phys 2008; 72: 1031-40.